Historical record - last NADAC effective date: 12/18/2013

Product Information

NIZATIDINE 150 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.2441 per EA under NDC 55111031060. Its NADAC has been published 7 times since Nov 28, 2013.

FDA first approved this application on Sep 15, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Nizatidine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

NIZATIDINE 150 MG CAPSULE

Nizatidine
$0.2441per EA
Low Outlier

Strength

150 mg/1

NDC

55111031060

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

12/18/2013

Active Ingredients

NIZATIDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA077314

FDA Approved

9/15/2005

TE Code

AB

On Market Since

9/15/2005

Pharmacological Classes

Histamine H2 Receptor Antagonists
Histamine-2 Receptor Antagonist

Price Statistics

The NADAC for NIZATIDINE 150 MG CAPSULE has been published 7 times since Nov 28, 2013, and over the history we have for it it has risen 2.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2441 per EA
All-time high$0.2441 (Jan 8, 2014)
All-time low$0.2375 (Nov 28, 2013)
Median price$0.2441
Average price$0.2413
Largest weekly change+2.8% (Dec 18, 2013)
Weeks tracked7
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+2.8%

Last surveyed Jan 8, 2014 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of NIZATIDINE 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for NIZATIDINE 150 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $0.2441 per EA (NDC 55111031060), effective Jan 8, 2014.

How has the price of NIZATIDINE 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for NIZATIDINE 150 MG CAPSULE has risen 2.8%. It has been tracked across 7 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NIZATIDINE 150 MG CAPSULE?

Since Nov 28, 2013, the NADAC for NIZATIDINE 150 MG CAPSULE has ranged from a low of $0.2375 (Nov 28, 2013) to a high of $0.2441 (Jan 8, 2014), with a median of $0.2441 per EA.

Are there cheaper alternatives to NIZATIDINE 150 MG CAPSULE?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NIZATIDINE 150 MG CAPSULE, is $0.2352 per EA — about 4% below NIZATIDINE 150 MG CAPSULE.

Who manufactures NIZATIDINE 150 MG CAPSULE?

NIZATIDINE 150 MG CAPSULE (NDC 55111031060) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.